SEARCH SITE

VIRGINIA LAW PORTAL

SEARCHABLE DATABASES

ACROSS SESSIONS

Developed and maintained by the Division of Legislative Automated Systems.

2007 SESSION

076591428
HOUSE JOINT RESOLUTION NO. 769
Offered January 18, 2007
Commending the Rx Partnership for its service to the Commonwealth through its many efforts to increase access to free medications for Virginia's uninsured citizens.
----------
Patrons-- Morgan, Athey, Hamilton, Jones, S.C., O'Bannon and Valentine; Senator: Wampler
----------

WHEREAS, more than 1 million Virginians are uninsured and have little or no access to healthcare, and more than 27% of these citizens have no access to prescription medications; and

WHEREAS, the Governor, the General Assembly, and the Joint Commission on Health Care helped initiate Rx Partnership in 2003 as a public/private partnership to increase access to prescription medications for Virginia’s eligible uninsured; and

WHEREAS, Rx Partnership is a free standing, nonprofit, tax-exempt organization that serves as a broker to solicit free prescription medications from pharmaceutical companies and arranges for their distribution to affiliate free clinics and community health centers with licensed pharmacies, which it credentials, monitors, and audits; and

WHEREAS, in communities in which no community-based clinic with a licensed pharmacy exists or in which one central pharmacy can more effectively serve multiple clinics, Rx Partnership fostered and assisted in the development of several central-fill pharmacy programs; and

WHEREAS, the Rx Partnership’s model is a much more streamlined, efficient, and cost effective process compared to the burdensome, costly, and time consuming individual patient assistance programs; and

WHEREAS, during the past two years, more than 45,000 prescriptions of Rx Partnership’s 162 medications have helped more than 9,700 eligible, uninsured, chronically ill patients at 20 affiliate clinics and health centers; and

WHEREAS, these medications have an estimated retail value in excess of $10.5 million and have been generously donated by Rx Partnership’s four current manufacturing partners, GlaxoSmithKline, Merck & Co., Novartis Pharmaceuticals, and Abbott; and

WHEREAS, the Rx Partnership model is unique in the nation and has been called “the gold standard” by a representative of Pharmaceutical Research and Manufacturers of America, received the Carilion Foundation Award of Excellence, and was featured as an outstanding grantee by the Sentara Health Foundation; and

WHEREAS, the Rx Partnership provides a tremendous return on the Commonwealth’s investment and has leveraged a cumulative $53 for every $1 match of state funds; and

WHEREAS, many of Virginia’s finest corporations and organizations have made financial commitments to Rx Partnership during fiscal year 2006, including Anthem Blue Cross and Blue Shield, Bedford Community Health Foundation, Bon Secours Richmond Health System, Campbell-Hoffman Foundation, Carilion Foundation, Centra Health Foundation, Eli Lilly and Company, The Jenkins Foundation, Mary Washington Hospital Foundation, Medical Society of Virginia Foundation, Medical Society of Virginia, Pharmaceutical Research and Manufacturers of America, Riverside Health System Foundation, Sentara Health Foundation, Sheltering Arms Fund of the Community Foundation, Williamsburg Community Health Foundation, and the Virginia Health Care Foundation; now, therefore, be it

RESOLVED by the House of Delegates, the Senate concurring, That the General Assembly hereby commend Rx Partnership on its outstanding service to the Commonwealth and its successful efforts to increase access to free prescription medications for Virginia’s uninsured citizens; and, be it

RESOLVED FURTHER, That Rx Partnership’s manufacturing partners, GlaxoSmithKline, Merck & Co., Novartis Pharmaceuticals, and Abbott, be recognized for their many contributions and encouraged to continue their visionary support and generous donations of free prescription medications to this innovative public/private partnership; and, be it

RESOLVED FURTHER, That Rx Partnership’s private sector financial contributors be commended and encouraged to continue their support of Rx Partnership; and, be it

RESOLVED FURTHER, That other pharmaceutical manufacturers of both generic and branded medications, as well as Virginia’s other corporate citizens and philanthropic entities, be strongly encouraged to participate in Rx Partnership, contributing their resources and support to this valuable public/private partnership; and, be it

RESOLVED FINALLY, That the Clerk of the House of Delegates prepare copies of this resolution for presentation to Rx Partnership and its partners GlaxoSmithKline, Merck & Co., Novartis Pharmaceuticals, and Abbott as an expression of the admiration and support of the General Assembly.